OCV-501

· Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OCV-501, covering 2021-03-02 to 2021-03-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia [Phase 2]

See pricing